Skylands Capital’s Veracyte VCYT Stock Holding History

Skylands Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-26,320	Closed	-$192K	–	236
2015 Q1	$192K	Sell	26,320 -172,143	-87%	-$1.41M	0.02%	203
2014 Q4	$1.92M	Buy	198,463 +24,463	+14%	+$191K	0.2%	103
2014 Q3	$1.7M	Buy	174,000 +162,600	+1,426%	+$2.13M	0.17%	127
2014 Q2	$195K	Buy	+11,400	New	+$164K	0.02%	223

Other funds holding VCYT

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Skylands Capital's VCYT Position: Q2 2015 in Review

Skylands Capital sold out of Veracyte (VCYT) in Q2 2015, closing a stake of 26,320 shares — an estimated $192K sold.

Skylands Capital first reported a position in VCYT in Q2 2014 and held it in 4 quarters. The position peaked at $1.92M in Q4 2014. 60 funds tracked by Wall St. Rank hold VCYT as of Q2 2015.

Skylands Capital reported no remaining Veracyte position as of Q2 2015 after selling out during the quarter.
Skylands Capital sold 26,320 Veracyte shares in Q2 2015, an estimated $192K.
Skylands Capital first reported a position in Veracyte in Q2 2014 and held it in 4 quarters.
Skylands Capital's Veracyte position peaked at $1.92M in Q4 2014.
60 funds tracked by Wall St. Rank held Veracyte as of Q2 2015.

Based on Skylands Capital's 13F filing for Q2 2015, filed 16 Jul 2015.